BioDelivery Sciences International, Inc. (NASDAQ: BDSI) Starts Presentation at 29th Annual ROTH Conference
BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. The company uses its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. The company's development strategy focuses on the utilization of the FDA's 505(b)(2) approval process which creates the potential for more timely and efficient approval of new formulations of previously approved therapeutics. BDSI's marketed products and those…







